OC01

Integrating PARP Inhibitors Into Treatment for Advanced Ovarian Cancer: Strategies for Improving Care and Outcomes

Date

April 1, 2023

Explore related products in the following collection:

Oncology Congress 2023

Speakers

Robert L. Coleman, MD

Chief Scientific Officer, The US Oncology Network

Chris Prakash, MD

Medical Director, Texas Oncology - Paris

Related Products

Thumbnail for BREAK #1

Thumbnail for Navigating New Evidence in the Treatment of HER2-Expressing Metastatic Breast Cancer in Rural and Underserved Communities

Navigating New Evidence in the Treatment of HER2-Expressing Metastatic Breast Cancer in Rural and Underserved Communities

Thumbnail for Integrating Novel Treatment Approaches for Cutaneous Squamous Cell Carcinoma: Strategies for Improving Equitable and Timely Access to Care

Integrating Novel Treatment Approaches for Cutaneous Squamous Cell Carcinoma: Strategies for Improving Equitable and Timely Access to Care

Thumbnail for Integrating the Latest Evidence in Melanoma Care to Address Health Equity

Integrating the Latest Evidence in Melanoma Care to Address Health Equity